Aspire BioPharma is trading at $8.93, up 5.75%, with biotech-sector strength the likeliest available context for the October 28 move, though no direct cause is confirmed.
- No verified company-specific announcement or fresh headline explaining the move was found; press-release listings show no new release for October 28.
- The supplied market context reports XBI up 2.18% during the regular session.